AstraZeneca Completes Biotech Biz Buyout For Up To $320M
Pharmaceutical giant AstraZeneca PLC said on Monday that it has completed its buyout of Neogene Therapeutics Inc., a biotechnology company, for up to $320 million....To view the full article, register now.
Already a subscriber? Click here to view full article